Evidence map›Paper›PMID 37988295›Full record

ArticleThe Journal of clinical endocrinology and metabolism2024

Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH.

Carla Moran, Nadia Schoenmakers, David Halsall, Susan Oddy, Greta Lyons, Sjoerd van den Berg, Mark Gurnell, Krishna Chatterjee

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Approach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis.The Journal of clinical endocrinology and metabolism · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Carla MoranEndocrine Section, Beacon Hospital, Dublin, D18 AK68, Ireland.
Nadia SchoenmakersWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.
David HalsallDepartment of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Susan OddyDepartment of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Greta LyonsWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.
Sjoerd van den BergDepartment of Clinical Chemistry, Erasmus Medical Center, 3015 GE Rotterdam, The Netherlands.
Mark GurnellWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0001-5745-6832
Krishna ChatterjeeWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-2654-8854
University of Cambridge · GBAddenbrooke's Hospital · GBErasmus MC · NLUniversity College Dublin · IE

Funding

Medical Research Council MRC_MC_UU_00014/40Wellcome TrustWellcome Trust 210755/Z/18/ZWellcome Trust 219296/Z/19/Z
6 · The paper itself

Abstract

Measurement of free thyroid hormones (THs) and thyrotropin (TSH) using automated immunoassays is central to the diagnosis of thyroid dysfunction. Using illustrative cases, we describe a diagnostic approach to discordant thyroid function tests, focusing on entities causing elevated free thyroxine and/or free triiodothyronine measurements with nonsuppressed TSH levels. Different types of analytical interference (eg, abnormal thyroid hormone binding proteins, antibodies to iodothyronines or TSH, heterophile antibodies, biotin) or disorders (eg, resistance to thyroid hormone β or α, monocarboxylate transporter 8 or selenoprotein deficiency, TSH-secreting pituitary tumor) that can cause this biochemical pattern will be considered. We show that a structured approach, combining clinical assessment with additional laboratory investigations to exclude assay artifact, followed by genetic testing or specialized imaging, can establish a correct diagnosis, potentially preventing unnecessary investigation or inappropriate therapy.

Indexed as

ThyroxineTriiodothyronineHumansThyroid Function TestsThyroid HormonesThyrotropinThyroid HormonesThyrotropinThyroxineTriiodothyronineassay interferencethyroid function teststhyroid hormone action

Identifiers

PMID37988295
PMCPMC10940260
OpenAlexW4388921958

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.